The differentiation of cardiac fibroblast to myofibroblast is the key process of cardiac fibrosis. In the study, we aimed to determine the function of E2F Transcription Factor 1 (E2F1) in human cardiac fibroblasts (HCFs) differentiation, search for its downstream genes and elucidate the function of them in HCFs differentiation. As a result, we found that E2F1 was up-regulated in TGF-β1-induced HCFs differentiation. Silencing the expression of E2F1 by siRNA in HCFs, we found that the expression of differentiation-related genes (Collagen-1, α-Smooth muscle actin, and Fibronectin-1) was significantly suppressed, combining with proliferation and migration assay, we determined that HCFs differentiation was decreased. Luciferase report assay and immunoprecipitation proved that the oncogene CCNE2 was a direct target gene of E2F1, overexpression of CCNE2 was found in differentiated HCFs, silencing the expression of CCNE2 by siRNA decreased HCFs differentiation. Our research suggested that E2F1 and its downstream target gene CCNE2 play a vital role in TGF-β1-induced HCFs differentiation, thus E2F1 and CCNE2 may be a potential therapeutic target for cardiac fibrosis.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8806588PMC
http://dx.doi.org/10.1080/21655979.2021.1972194DOI Listing

Publication Analysis

Top Keywords

hcfs differentiation
24
e2f transcription
8
transcription factor
8
factor e2f1
8
human cardiac
8
cardiac fibroblasts
8
differentiation
8
cardiac fibrosis
8
hcfs
8
tgf-β1-induced hcfs
8

Similar Publications

Article Synopsis
  • Extracellular vesicles (EVs) play a significant role in heart failure (HF), but the specific impact of circulating EVs (CEVs) in HF is still not fully understood.
  • In a study, a comparison between CEVs from heart failure patients (HCEVs) and those from healthy individuals (NCEVs) revealed 6 proteins that were upregulated and 9 that were downregulated in HCEVs, indicating key differences in their biological functions.
  • The upregulated proteins in HCEVs were linked to inflammation and metabolic processes, while the downregulated proteins affected cell growth and repair, leading to increased inflammation and impaired regenerative ability in heart cells, ultimately contributing to harmful cardiac remodeling in HF.
View Article and Find Full Text PDF

Cardiac fibrosis is a commonly seen pathophysiological process in various cardiovascular disorders, such as coronary heart disorder, hypertension, and cardiomyopathy. Cardiac fibroblast trans-differentiation into myofibroblasts (MFs) is a key link in myocardial fibrosis. LncRNA PVT1 participates in fibrotic diseases in multiple organs; however, its role and mechanism in cardiac fibrosis remain largely unknown.

View Article and Find Full Text PDF

Corneal fibroblasts are involved in the wound healing of the cornea with proliferation, migration, and differentiation processes. Coenzyme Q10 (CoQ10) and vitamin E can enhance corneal wound healing when applied after a corneal lesion as an eye drop. Thus, this study was performed to determine the potential efficiency of a CoQ10 ophthalmical solution containing a CoQ10 and vitamin E D-α-tocopherol polyethylene glycol 1000 succinate (TPGS)-derived formulation in human corneal fibroblasts (HCFs) .

View Article and Find Full Text PDF

Background: Pulmonary hypertension (PH)-induced right ventricular (RV) failure (PH-RVF) is a significant prognostic determinant of mortality and is characterized by RV hypertrophy, endothelial-to-mesenchymal transition (EndMT), fibroblast-to-myofibroblast transition (FMT), fibrosis, and extracellular matrix (ECM)-remodeling. Despite the importance of RV function in PH, the mechanistic details of PH-RVF, especially the regulatory control of RV EndMT, FMT, and fibrosis, remain unclear. The action of transcription factor Snai1 is shown to be mediated through LOXL2 recruitment, and their co-translocation to the nucleus, during EndMT progression.

View Article and Find Full Text PDF

Exosomes derived from induced cardiopulmonary progenitor cells alleviate acute lung injury in mice.

Acta Pharmacol Sin

August 2024

The Fifth Affiliated Hospital, Key Laboratory of Molecular Target & Clinical Pharmacology, the NMPA and State Key Laboratory of Respiratory Disease, School of Pharmaceutical Sciences, Guangzhou Medical University, Guangzhou, 511436, China.

Article Synopsis
  • Cardiopulmonary progenitor cells (CPPs) are important for developing the heart and lungs during embryogenesis but disappear after birth; their potential use in treating pulmonary heart disease (PHD) highlights the need for a consistent source of these cells.
  • In this research, human cardiac fibroblasts (HCFs) were reprogrammed into CPP-like cells (induced CPPs, or iCPPs) using specific genetic factors, and these cells were evaluated for their ability to treat acute lung injury (ALI).
  • The study found that exosomes from iCPPs could significantly reduce LPS-induced lung inflammation and improve lung function in a mouse model of ALI, suggesting a promising approach for treating lung injuries and aiding
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!